Pilot Study Comparison of Combigan BID vs Simbrinza TID in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Brimonidine/timolol (Primary) ; Brimonidine/brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 14 Mar 2018 Planned End Date changed from 1 Sep 2017 to 1 Apr 2018.
- 14 Mar 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
- 14 Mar 2018 Status changed from recruiting to active, no longer recruiting.